|Values are valid only on day of printing.|
Diagnosis of HIV-1 and/or HIV-2 infection in cadaveric or hemolyzed serum specimens from symptomatic patients with or without risk factors for HIV infection (assay kit is FDA-approved for testing cadaveric or hemolyzed blood specimens)
|Test ID||Reporting Name||Available Separately||Always Performed|
|HIVDI||HIV Ab Confirm / Differentiation, S||Yes||No|
|HIV2L||HIV-2 Ab Confirmation, S||Yes||No|
This test begins with HIV-1/-2 antibody EIA. If HIV-1/-2 antibody EIA is reactive, then HIV-1/-2 antibody differentiation is performed at an additional charge.
HIV-1 and HIV-2 antibody differentiation test begins with the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test, with the following reflex testing. In specimens with indeterminate HIV-1 antibody but negative HIV-2 antibody results, HIV-1 antibody confirmation by Western blot is performed at an additional charge. In specimens with reactive or unreadable results for both HIV-1 and HIV-2 antibodies, HIV-1 antibody confirmation by Western blot and HIV-2 antibody confirmation are performed at additional charges. In specimens with negative HIV-1 antibody, but reactive HIV-2 antibody results, HIV-2 antibody confirmation is performed at an additional charge.
This is the appropriate test for testing symptomatic individuals.
This test is not appropriate for asymptomatic individuals. To screen for HIV antibodies in hemolyzed specimens from asymptomatic individuals with or without risk factors for HIV infection, order HV1CM / HIV-1 and HIV-2 Antibody Screen for Hemolyzed Specimens, Serum.
See HIV Testing Algorithm (Fourth Generation Screening Assay) Including Follow-up of Reactive HIV Rapid Serologic Test Results in Special Instructions.
Enzyme Immunoassay (EIA)-Screening Procedure